Dr Cornelissen’s project aims to detect pancreatic tumours earlier and evaluate treatments faster using imaging equipment (PET scanners) routinely used in hospitals. He has attached a radioactive atom to a chemotherapy drug and will test whether PET scanners can image the molecule to quickly confirm the presence and position of tumours. He will also test whether using this technique to measure drugs in the body before and after chemotherapy can determine whether the treatment is working.
Read the full press release on the PCRF website.